Paid Clinical Trials in Chattanooga, TN
As of June 2026, 144 paid clinical trials are recruiting in Chattanooga, Tennessee. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Chattanooga offers studies at sites including T C Thompson Children's Hospital for conditions such as Carcinoma, Non-Small-Cell Lung, Generalized Myasthenia Gravis, Non-Small Cell Lung Cancer, Atrial Fibrillation. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Chattanooga
Trials by drug in Chattanooga
Filter results
144 clinical trials
↓ Download CSVStudy of Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
About research studies in Chattanooga
Chattanooga has approximately 144 recruiting research studies across a wide range of therapeutic areas. Tennessee is home to Vanderbilt University Medical Center and St. Jude Children's Research Hospital — world leaders in pediatric oncology and personalized medicine.
Top Research Study Locations in Chattanooga
Researchers run research studies in Chattanooga, TN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| T C Thompson Children's Hospital | Acute Myeloid Leukemia, Adrenal Gland Pheochromocytoma, Anaplastic Kidney Wilms Tumor | 8 |
| Erlanger Health System | AChR-Ab Seropositive Generalized Myasthenia Gravis, Atrial Fibrillation, Generalized Myasthenia Gravis | 7 |
| Memorial Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Childhood Extracranial Germ Cell Tumor | 5 |
| Southeast Renal Research Institute | Atherosclerotic Cardiovascular Disease in Patients With ESKD, Diabetic Kidney Disease (DKD), Focal Segmental Glomerulosclerosis | 5 |
| ClinSearch, LLC | Chronic Obstructive Pulmonary Disease, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis | 3 |
| Erlanger Health, Inc. | Cardiovascular Disease, Endometrioid Ovarian Cancer, Fallopian Tube Cancer | 3 |
| GSK Investigational Site | Multiple Myeloma, Neoplasms, Head and Neck, Non-alcoholic Fatty Liver Disease | 3 |
| Tennessee Oncology | Advanced Solid Tumors, B-Cell Non-Hodgkins Lymphoma, Colorectal Cancer (CRC) | 3 |
| Tennessee Oncology - Chattanooga | Carcinoma, Non-Small-Cell Lung, Melanoma, Metastatic Castration-resistant Prostate Neoplasms | 3 |
| Tennessee Oncology Chattanooga | Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis | 3 |
| Tennessee Oncology, PLLC - Chattanooga Downtown | Advanced Non-Small Cell Lung Cancer, Cancer of the Prostate, Carcinoma, Non-Small-Cell Lung | 3 |
| Tennessee Oncology, PLLC - Chattanooga Med Park II | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Cancer of the Prostate | 3 |
| Tennessee Oncology, PLLC - Chattanooga Memorial | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Cancer of the Prostate | 3 |
| University Diabetes & Endocrine Consultants | Diabetes Mellitus, Type 1, T1D, T1DM | 3 |
| Vascular Institute of Chattanooga | Arteriovenous Fistula, Chronic Total Occlusion of Artery of the Extremities, End-stage Renal Disease | 3 |
| WR-ClinSearch | Focal Epilepsy, Obesity Associated With Defects in Leptin-melanocortin Pathway | 3 |
| Clinical Trial Site | Generalized Myasthenia Gravis, High Cardiovascular Risk, High Risk Cardiovascular Disease | 2 |
| Chattanooga's Program in Women's Oncology | Cervical Cancer, Solid Tumor | 2 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight | 2 |
| Tennessee Oncology, PLLC | Acinar Cell Carcinoma, Advanced Cancer, Breast Cancer | 2 |
| Tennessee Oncology, PLLC - Investigational Drug Services/Supply Storage | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, Renal Cell | 2 |
| WR-Clinsearch, LLC | Atherosclerotic Cardiovascular Disease (ASCVD), COVID-19 SARS-CoV-2 Infection, Elevated Lp(a) | 2 |
| Woolfson Eye Institute | Forme Fruste Keratoconus (FFK), Keratoconus, Down Syndrome (DS) | 2 |
| Chattanooga Heart Institute | Acute Myocardial Infarction (AMI), Cardiovascular Risk | 1 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
Active & Upcoming Studies in Chattanooga (2026)
Recruiting trials in Chattanooga grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (54 active studies)
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · Phase 1, Phase 2 · Pfizer
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
Diabetes & metabolic (13 active studies)
Neurology & pain (10 active studies)
- Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation · Javelin Medical
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Cardiovascular (8 active studies)
- Study of Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital · Phase 2 · Kardigan, Inc.
- Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation · Javelin Medical
Vaccines (2 active studies)
Eye & vision (1 active study)
- Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD · Phase 3 · AbbVie
Pediatric (1 active study)
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
Common conditions studied in Chattanooga
- Carcinoma, Non-Small-Cell Lung (4 active studies). Recruiting Carcinoma, Non-Small-Cell Lung studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Generalized Myasthenia Gravis (4 active studies). Recruiting Generalized Myasthenia Gravis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-Small Cell Lung Cancer (4 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Atrial Fibrillation (3 active studies). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- Breast Cancer (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Chronic Lymphocytic Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Chattanooga
- AstraZeneca
- Children's Oncology Group
- Pfizer
- AbbVie
- Boehringer Ingelheim
Local regulations and guidelines
Clinical trials in Tennessee are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Tennessee research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Chattanooga. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Chattanooga
Hipa.ai aggregates every recruiting study in Chattanooga from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Chattanooga?
There are approximately 144 recruiting clinical trials in Chattanooga, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Chattanooga pay participants?
Most recruiting trials in Chattanooga compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Chattanooga?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Chattanooga?
The most common conditions under active study in Chattanooga include Carcinoma, Non-Small-Cell Lung (4), Generalized Myasthenia Gravis (4), Non-Small Cell Lung Cancer (4), Atrial Fibrillation (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Chattanooga?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Chattanooga on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Chattanooga?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Chattanooga?
Recruiting research sites in Chattanooga include T C Thompson Children's Hospital, Erlanger Health System, Memorial Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Chattanooga right now?
The largest active categories in Chattanooga are Cancer & tumors (54), Diabetes & metabolic (13), Neurology & pain (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.